Clinical Trials Logo

Stage II Testicular Seminoma clinical trials

View clinical trials related to Stage II Testicular Seminoma.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT05345158 Recruiting - Clinical trials for Stage II Testicular Seminoma

R-RPLND as First-line Treatment for Clinical Stage IIA/B Testicular Seminoma

Start date: February 23, 2022
Phase: N/A
Study type: Interventional

This study will investigate the safety and efficacy of using robotic retroperitoneal lymph node dissection (R-RPLND), a minimally invasive surgical approach, as the first-line of treatment for stage IIA/B (or equivalent) seminoma patients. R-RPLND will be trialed as an alternative to chemotherapy, radiation therapy (for seminoma patients) and open RPLND in this study.